Rocket Pharmaceuticals (RCKT) Tops Q3 EPS by 4c

Rocket Pharmaceuticals (NASDAQ: RCKT) reported Q3 EPS of ($0.45), $0.04 better than the analyst estimate of ($0.49).

For earnings history and earnings-related data on Rocket Pharmaceuticals (RCKT) click here.

You May Also Be Interested In

• Trump: Witkoff And Kushner Had Productive Meeting With Iran
• Ferguson plc (FERG) 2500 contracts of October 250 calls trade, share price up 2%
• Brinker International (EAT) call put ratio 1 call 1.9 puts as share price up 2.7%